mPEG-Silane
Products
MSDS
mPEG-Silane

CatalogID: 10021 Purity: ≥95%

  • Synonyms:
    Methoxy-PEG-Silane
  • Purity:
    ≥95%
  • Recommended Storage Condition:
    Store at -5°C,keep in dry and avoid sunlight.
  • Uses:
    Applicated in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

mPEG-Silane (Methoxy PEG Silane) is a linear monofunctional mPEG derivative containing an inert methoxy (-OCH3) end cap and a reactive alkoxysilane or triethoxysilane terminal group.  The silane moiety undergoes hydrolytic condensation with surface hydroxyl (-OH) groups on glass substrates, quartz, silicon wafers, titanium dioxide (TiO2), and metal oxides.   It is a premier silanization reagent designed for covalent surface modification, nanoparticle functionalization, and anti-biofouling PEG coatings across inorganic and polymeric substrates.

Cited Publications

The Methoxy PEG silane derivative has been cited in peer-reviewed scientific publications. Browse the references below to learn more.

  1. Happonen, Emilia; Dang, Yijing; Wang, Jiajia; Saarela, Silja; Sivonen, Minna; Zakir, Mohammed; et al. (2025). Drug-Free Approach to Regulate Undruggable Proto-Oncogene
    MYC Using Biomimetic Porous Nanoparticles for Cancer Immunotherapy. ACS Publications. Journal contribution. https://doi.org/10.1021/acsami.5c05042.s001
  2. NMR studies of PEG chain dynamics on mesoporous silica nanoparticles for minimizing non-specific binding, Xiaochong Li,  Yang Liu, Edmond C. N. Wong and  Mitchell A. Winnik,  Nanoscale, 2025,17, 14759-14771, https://doi.org/10.1039/D5NR00936G
  3. Wen, J.; Lei, C.; Hua, S.; Cai, L.R.Y.; Dai, H.; Liu, S.Y.; Li, Y.W.; Ivanovski, S.; Xu, C. Regulation of macrophage uptake through the bio-nano interaction using surface functionalized mesoporous silica nanoparticles with large radial pores. J. Mater. Chem. B 2024, 13, 137–150. https://doi.org/10.1039/D4TB01124D 
  4. Daichi Nakajima, Nozomi Takahashi, Takanari Inoue, Shin-ichiro M. Nomura, Hideaki T. Matsubayashi,
    A unified purification method for actin-binding proteins using a TEV-cleavable His-Strep-tag, MethodsX, Volume 13, 2024, 102884, ISSN 2215-0161, https://doi.org/10.1016/j.mex.2024.102884
  5. Wen H, Martínez MG, Happonen E, et al. A PEG-assisted membrane coating to prepare biomimetic mesoporous silicon for PET/CT imaging of triple-negative breast cancer. Int J Pharm. 2024;652:123764. doi:10.1016/j.ijpharm.2023.123764 
  6. Wen, H.; Poutiainen, P.; Batnasan, E.; Latonen, L.; Lehto, V.-P.; Xu, W. Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer. Pharmaceutics 2023, 15, 2507. https://doi.org/10.3390/pharmaceutics15102507 
  7. Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy, Published in Volume 133, Issue 19 on October 2, 2023J Clin Invest. 2023;133(19):e171356. https://doi.org/10.1172/JCI171356
  8. Sekine, R., Tsuno, S., Irokawa, H., Sumitomo, K., Han, T., Sato, Y., Nishizawa, S., Takeda, K., & Kuge, S. (2023). Inhibition of SARS-CoV-2 nucleocapsid protein–RNA interaction by guanosine oligomeric RNA. The Journal of Biochemistry, 173(6), 447-457. https://doi.org/10.1093/jb/mvad008 
  9. Functionalized silica nanoplatform as a bimodal contrast agent for MRI and optical imaging, Nanoscale, 2021,13, 16509-16524, https://doi.org/10.1039/D1NR04972K
  10. ​Wack, M., Wiegand, T., Frischknecht, F. and Cavalcanti-Adam, E. A. (2020). An in vitro DNA Sensor-based Assay to Measure Receptor-specific Adhesion Forces of Eukaryotic Cells and Pathogens. Bio-protocol 10(17): e3733. DOI: 10.21769/BioProtoc.3733
  11. Lee, J., Choi, S. W., Park, M., Um, W., Kwon, S., Kim, C. H., Joo, H., You, D. G., Lee, J. A., Shin, S., Kang, H., Ghahari, F., Kim, J., & Park, J. H. (2025). Hematite-embedded mesoporous nanoparticles for ferroptosis-inducing cancer sonoimmunotherapy. Journal of Controlled Release, 113990. https://doi.org/10.1016/j.jconrel.2025.113990

View more publications citing Biopharma PEG products.

Related Products & Categories

Need Custom mPEG-Silane Molecular Weights or Bulk Synthesis?

Biopharma PEG supplies high-purity mPEG-Silane in standard molecular weights for research, nanomedicine development, and industrial surface modification in both non-GMP and GMP grades.

We also offer custom synthesis for specific PEG chain lengths and bulk quantities tailored to your surface functionalization project.

Request a Quote / Custom Synthesis Inquiry

Top